Document is current
Any future updates will be listed below
-
Authors
Skumlien, Martine https://orcid.org/0000-0003-3552-2653
Mokrysz, Claire
Freeman, Tom P.
Wall, Matthew B.
Bloomfield, Michael https://orcid.org/0000-0002-1972-4610
Lees, Rachel
Borissova, Anna
Petrilli, Kat
Carson, James
Coughlan, Tiernan
Ofori, Shelan
Langley, Christelle https://orcid.org/0000-0001-5061-2820
Sahakian, Barbara J. https://orcid.org/0000-0001-7352-1745
Curran, H. Valerie
Lawn, Will https://orcid.org/0000-0002-0143-2724
-
Funding
Funding for this research was provided by:
Aker Foundation
RCUK | Medical Research Council (MR/P012728/1, MR/P012728/1)
DH | National Institute for Health Research (N/A)
Wellcome Trust (200181/Z//15/Z, 200181/Z//15/Z)
Wallitt Foundation, Eton College
- License Information
-
More Information
Article History
Received: 24 September 2021
Revised: 15 March 2022
Accepted: 18 March 2022
First Online: 6 April 2022
Competing interests
: BJS consults for Cambridge Cognition and Greenfield BioVentures. HVC has consulted for Janssen Research and Development. MBW’s primary employer is Invicro LLC, a contract research organisation that performs commercial research for the pharmaceutical and biotechnology industries. The remaining authors have no conflicts of interest to disclose.
